Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

XILIO THERAPEUTICS INC (XLO)

37 + Investors. Track Smart Money conviction in XLO. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
2Q ▲
Buyers last Q
53%

Smart Money Signals — XLO

Based on 37 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added XLO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
37 hedge funds hold XLO right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q
+4 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 53% buying

16 buying14 selling
Last quarter: 16 funds bought or added vs 14 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+7 vs last Q)

new funds entering per quarter
Funds opening a new XLO position: 7 → 5 → 4 → 11. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 35% long-term, 32% new

35% conviction (2yr+) 32% medium 32% new
Of the 37 current holders: 13 (35%) held >2 years, 12 held 1–2 years, and 12 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +93%, value +46%

Value
+46%
Shares
+93%
Last quarter: funds added +93% more shares while total portfolio value only changed +46%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

8 → 7 → 5 → 4 → 11 new funds/Q
New funds entering each quarter: 7 → 5 → 4 → 11. A growing number of institutions are discovering XLO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 43% of holders stayed 2+ years

43% veterans 16% 1-2yr 41% new
Of 37 current holders: 16 (43%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds
9 of 37 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: XLO

How many hedge funds hold XLO — quarterly history vs. share price
Quarterly hedge fund ownership of XLO vs. share price

Market Analysis: XLO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: XLO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

9 top-rated funds 1 high-conviction
Consensus
4.3
/ 10
breadth
×
Elite
1.0
/ 10
conviction
Hedge Fund Positioning: XLO
2026 Q1 Stats Unlock in 14 days 37 + Investors

Track Smart Money conviction in XLO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 37 35 5.71%
13F Shares 40M 21M 93.07%
Total Value $25M $17M 46.41%
New Positions 11 4 +7
Increased Positions 5 6 -1
Closed Positions 9 3 +6
Reduced Positions 5 4 +1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: XLO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

37 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in XLO. Verified SEC 13F-HR filings.

Top 25 institutional holders of XLO — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 AJU IB Investment Co., Ltd. 1.88% 667,742 $427K
2 Empery Asset Management, LP 0.67% 1,183,040 $757K
3 Bain Capital Life Sciences Investors, LLC 0.36% 7,372,686 $4.7M
4 Merck & Co., Inc. 0.34% 1,483,758 $950K
5 GILEAD SCIENCES, INC. 0.30% 9,105,451 $5.8M
6 STEMPOINT CAPITAL LP 0.22% 2,030,028 $1.3M
7 Sio Capital Management, LLC 0.21% 2,134,537 $1.4M
8 Frazier Life Sciences Management, L.P. 0.10% 5,915,091 $3.8M
9 Velan Capital Investment Management LP 0.06% 170,000 $109K
10 Stonepine Capital Management, LLC 0.06% 126,270 $81K
11 Ghisallo Capital Management LLC 0.03% 1,113,222 $713K
12 GSA CAPITAL PARTNERS LLP 0.01% 147,966 $95K
13 Point72 Asset Management, L.P. 0.00% 4,000,000 $2.6M
14 INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 0.00% 10,000 $6K
15 Pinnacle Financial Group, LLC / IL 0.00% 10,000 $6K
16 Dunhill Financial, LLC 0.00% 10,274 $7K
17 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% 56,081 $36K
18 RENAISSANCE TECHNOLOGIES LLC 0.00% 344,416 $220K
19 XTX Topco Ltd 0.00% 17,304 $11K
20 Key FInancial Inc 0.00% 830
21 HRT FINANCIAL LP 0.00% 31,886 $20K
22 TWO SIGMA INVESTMENTS, LP 0.00% 62,032 $40K
23 Private Wealth Management Group, LLC 0.00% 310
24 CITADEL ADVISORS LLC 0.00% 436,216 $279K
25 MORGAN STANLEY 0.00% 839,850 $538K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — XILIO THERAPEUTICS INC (XLO)

What does the Smart Money Trend signal show for XLO?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added XLO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for XLO?

Slight buying edge — 53% buying: Last quarter: 16 funds bought or added vs 14 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for XLO holders?

Smaller funds dominant — 8% AUM from top-100: 9 of 37 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held XLO?

Mixed — 35% long-term, 32% new: Of the 37 current holders: 13 (35%) held >2 years, 12 held 1–2 years, and 12 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.